Ron Burgundy Posted December 2, 2013 Share Posted December 2, 2013 A class action over birth defects linked to the morning sickness drug thalidomide was settled in an Australian court Monday, with the British distributor agreeing to pay victims Aus$89 million (US$81 million). Lawyers representing some 100 Australian and New Zealand victims of the drug told the Victorian Supreme Court that settlement had been reached with Diageo, which owns now-defunct thalidomide distributor The Distillers Company. "It has been difficult and challenging litigation but this settlement will now see a group of people receive compensation, a result that goes some distance to finally addressing a very grave historic wrong," said lawyer for the victims, Peter Gordon. View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.